相关实验视频

Updated: Jul 17, 2025

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.2K

洗过的微生物群移植用于Clostridioides difficile感染:一个国家多中心的现实研究

Xia Wu1,2, Ru Jun Ai1,2, Jie Xu1,2

  • 1Department of Microbiota Medicine & Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China.

Journal of digestive diseases
|September 8, 2023
PubMed
概括

洗微生物种移植 (WMT) 有效治疗困难菌感染 (CDI),达到90.7%的治愈率. 这项研究强调WMT是CDI患者的安全和有价值的治疗选择,包括那些患有严重疾病的患者.

关键词:
克洛斯特里迪奥伊德困难感染.克罗恩氏病是什么 克罗恩氏病是什么超内镜肠道管道性结肠炎是一种洗净的微生物群移植移植

更多相关视频

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

2.9K
Murine Fecal Isolation and Microbiota Transplantation07:32

Murine Fecal Isolation and Microbiota Transplantation

Published on: May 26, 2023

4.1K

相关概念视频

Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
204